title: The effects of CD26/DPP IV-targeted therapy on acute allograft rejection.
authors.affiliation: Harvard Medical School, Dept of Surgery, Brigham & Women's Hospital, Boston, MA 02115, USA.
authors.forename: S
authors.initials: S
authors.lastname: Korom
authors.forename: I
authors.initials: I
authors.lastname: De Meester
authors.forename: K
authors.initials: K
authors.lastname: Onodera
authors.forename: T H
authors.initials: TH
authors.lastname: Stadlbauer
authors.forename: M
authors.initials: M
authors.lastname: Borloo
authors.forename: A M
authors.initials: AM
authors.lastname: Lambeir
authors.forename: J W
authors.initials: JW
authors.lastname: Kupiec-Weglinski
mesh_terms: D000818:Animals; D018819:Dipeptidyl Peptidase 4 / Q000096:biosynthesis* / Q000097:blood / Q000378:metabolism*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D010880:Piperidines; D011480:Protease Inhibitors; C016695:prodipin; D018819:Dipeptidyl Peptidase 4